VR Logo

Acorda Therapeutics Inc. (ACOR) download report


Healthcare | Drugs & Pharma

Acorda Therapeutics Inc. (ACOR) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States.

IPO Date: 10-Feb-2006

Founder, CEO, Pres & Director: Dr. Ron Cohen M.D.

Chief Operating Officer: Ms. Lauren M. Sabella

Listing: NASDAQ: ACOR

Country: United States

Headquarters: Ardsley, NY

Website: https://www.acorda.com

Key Facts

Market cap: $10.96 Mln

Revenue (TTM): $122.74 Mln

Earnings (TTM): $-95.02 Mln

Cash: $31.87 Mln

Total Debt: $193.35 Mln

Insider's Holding: 1.33%

Liquidity: Low

52 Week range: $0.28 - 4.99

Shares outstanding: 24,277,800

10 Years Aggregate:

  • CFO: $257.02 Mln
  • EBITDA: $-357.87 Mln
  • Net Profit: $-500.68 Mln

Stock Performance

Time Period Acorda Therapeutics (ACOR) S&P BSE Healthcare S&P Small-Cap 600
YTD-80.75-11.15-9.40
1 month4.575.0711.02
3 months-43.833.918.82
1 Year-87.29-11.68-6.43
3 Years-70.2822.4110.91
5 Years-67.2812.758.84
10 Years-43.1412.3110.89
As on 11-Aug-2022
Year Acorda Therapeutics (ACOR) S&P Small-Cap 600 S&P BSE Healthcare
2021-42.2825.2720.87
2020-66.179.5761.45
2019-86.9120.86-3.55
2018-27.24-9.70-5.89
201714.1011.730.49
2016-56.0524.74-12.88
20154.67-3.3615.06